# RFK Jr. still eager to fund vaccine trial that would expose babies to deadly virus

> **Open Intelligence Dossier** · First detected: 2026-10-09 20:40 UTC · Category: Health

## Executive Summary
A controversial vaccine trial touted by RFK Jr receives authorization and funding preparations in Guinea-Bissau.

## Intelligence Brief
Recent reporting from The Guardian and UA.NEWS outlines a controversial medical development concerning a vaccine trial in Guinea-Bissau that has gained backing and financial maneuvering from American health officials. According to the coverage, a vaccine trial previously touted by RFK Jr has received the necessary go-ahead to proceed within the West African nation. Concurrently, reporting indicates that the office of the CDC director ordered a specific financial reserve of $1.6 million to be set aside specifically for this Guinea-Bissau trial. The unfolding situation places international attention on the intersection of American public health administration and foreign medical experimentation. The coverage from both outlets emphasizes the contentious nature of the initiative, particularly highlighting the involvement and public support of RFK Jr.


The Guardian focuses primarily on the authorization milestone achieved within Guinea-Bissau, framing the approval as a significant development for a study that has drawn substantial controversy. Meanwhile, UA.NEWS contributes specific logistical details regarding the financial allocation originating from the CDC director&amp;#039;s office. Neither outlet specifies the exact timeline for when the trial will officially commence its physical procedures on the ground, leaving open questions about the immediate next steps of the project. Contextually, this emerging trend builds upon ongoing discussions regarding the oversight, direction, and funding priorities of United States public health agencies under current leadership. The association of prominent figures like RFK Jr with foreign clinical trials brings heightened scrutiny to how federal resources are deployed internationally.


Coverage does not yet detail the complete historical background of the specific vaccine being tested or the full regulatory review process it underwent prior to gaining authorization in Guinea-Bissau. Readers are provided with the immediate financial and political markers of the event without extensive prior history of the trial. As the situation continues to develop, observers and interested parties will be monitoring further announcements from the involved outlets regarding the actual disbursement of the $1.6 million and the operational timeline within Guinea-Bissau. Coverage does not yet specify whether additional regulatory hurdles remain or how local populations in Guinea-Bissau are responding to the incoming trial. Future reporting is expected to track the physical rollout of the study and any formal responses from international health bodies regarding the funding mechanism and the safety parameters of the trial protocol.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| The Guardian | Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau | [Source Link](https://news.google.com/rss/articles/CBMiigFBVV95cUxQcUhibHRCZ05LR2ZkRkZQUlFKUy1iTW5rU0wtQmZyQjlzNEFRclpSYThieWdJZGZXTnk1MFdtaWc5SnlXRnk1N1JkenlNZ0dKNVRaNDAxYUJpVmdwNWU0WV9NMmU0ZDlwdS13M1BQOENVbG53djhJYzZ4b2R0dHJ5STZwRUxEV3lCOHc?oc=5) |
| UA.NEWS | CDC director’s office ordered $1.6 million reserved for Guinea-Bissau trial — Ars Technica | [Source Link](https://news.google.com/rss/articles/CBMivgFBVV95cUxQQWFQQkFOcjd0RXgtbkcwRWZfX3FsZnVfR0JMdHhzTDdSbnhCenNVTjNGNFZyX3phaXJuVjk5R3ZSSU9VVjNpOFpXR01xbHpETkNQVE96eUdtRFRHTVFMamhMT09rSVQ1dVBjNXZlc2hucElyVlJjOGF6WUZqajVJam5fSGtJUGxsdHJ4aXlWTHNaSF9TUjBwZ05pOHIyZEx4a093SG5mM1BaY3ljdEZHdE4xYU42SFJZTTc3ekpR?oc=5) |

---
*Canonical Source: https://pulse.byoaiapps.com/trend/2026-10-09/rfk-jr-still-eager-to-fund-vaccine-trial-that-would-expose-babies-to-deadly*
